Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.

The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The following is a summary of “Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls,” published in the January 2025 issue of Endocrinology by She et al. Researchers ...

JSW MG Motor India has introduced the MG M9 at Auto Expo 2025, marking it as "the nation's inaugural electric three-row presidential limousine." This launch is part of MG Select, a new luxury ...

Attribution (BY): Credit must be given to the creator. Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention as long-acting peptide therapeutics for type 2 diabetes and ...

But, boy, do they attract attention, and that’s their main raison d’etre. So it is with the latest MG, the Cyberster. Its electrically operated scissor doors have garnered as much attention as ...